Australian Medication Safety Services
  • Home
  • Advisory Services & Analysis
  • Expert Clinical Guidance
  • Education
  • Medical Writing
  • Research Design & Supervision
  • Medicolegal Consulting
  • Comments
Select Page

The elderly in clinical trials – a vexed question

Apr 30, 2018

The New York Times has recently discussed an elephant in the room – although the elderly are the most frequent users of many medications, they are systematically excluded from many clinical trials. The resultant evidence vacuum emphasizes the need to tread warily when using medicines for older people  https://www.nytimes.com/2018/04/13/health/elderly-clinical-trials.html

Recent Posts

  • Clinical trial reveals modest benefit for pharmacotherapy of methamphetamine use disorder.
  • Analysis of fatal adverse drug events encountered in the ED
  • COVID19 and remdesivir reactions.
  • Risk of atypical hip fracture increased with extended duration of treatment with bisphosphonates
  • Polypill delivers reduced cardiovascular events

Archives

  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018

Copyright © 2021 Australian Medication Safety Services | PO Box 179, Glen Osmond, South Australia 5064 | Email: admin@medsafetyaustralia.com.au

Website Design